Pure Global

ANTI- A1 LECTIN. - COFEPRIS Registration 1038R2020 SSA

Access comprehensive regulatory information for ANTI- A1 LECTIN. (ANTI- A1 LECTIN.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1038R2020 SSA and manufactured by KABLA COMERCIAL, S.A. DEC.V.. The device was registered on August 04, 2020.

This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
1038R2020 SSA
ANTI- A1 LECTIN.
COFEPRIS Analysis ID: 1038R2020 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

PARADETERMINARELSUBGRUPODESANGREA1. AGENTES DE DIAGNร“STICO PARA USO INVITRO, PARA USO EXCLUSIVO ENLABORATORIOS CLรNICOS ร“ DE GABINETE.

English

TO DETERMINE the blood subgroupA1. DIAGNOSTIC AGENTS FOR INVITRO USE, FOR EXCLUSIVE USE IN CLINICAL LABORATORIES OR CABINET.

Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. AGENTES DE DIAGNร“STICO
Product Type (English)
III. DIAGNOSTIC AGENTS
Trade Name (Spanish)
ANTISUERO PARA TIPIFICAR SANGRE.
Trade Name (English)
ANTISERUM TO TYPE BLOOD.
Registration Information
Analysis ID
1038R2020 SSA
Registration Date
August 04, 2020
Manufacturer / Fabricante
Name (English)
KABBALAH COMMERCIAL, S.A. DEC.V.